National Bank of Canada
HELP

National Bank of Canada’s Helus Pharma Inc. Common Stock HELP Stock Holding History

National Bank of Canada’s Portfolio HELP Stock Details HELP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25.1K Buy
5,357
+225
+4% +$1.13K ﹤0.01% 2189
2026
Q1 		$17.4K Sell
5,132
-276
-5% -$1.78K ﹤0.01% 2208
2025
Q4 		$32.5K Sell
5,408
-69
-1% -$444 ﹤0.01% 2052
2025
Q3 		$23.5K Buy
5,477
+145
+3% +$1.03K ﹤0.01% 2128
2025
Q2 		$32.8K Buy
5,332
+81
+2% +$589 ﹤0.01% 2058
2025
Q1 		$23.1K Buy
5,251
+5,107
+3,547% +$44.2K ﹤0.01% 2056
2024
Q4 		$1.27K Sell
144
-70
-33% -$711 ﹤0.01% 2624
2024
Q3 		$1.9K Buy
214
+94
+78% +$930 ﹤0.01% 2362
2024
Q2 		$1.21K Hold
120
– – ﹤0.01% 2484
2024
Q1 		$1.6K Hold
120
– – ﹤0.01% 2485
2023
Q4 		$1.78K Sell
120
-42
-26% -$782 ﹤0.01% 2469
2023
Q3 		$3.52K Hold
162
– – ﹤0.01% 2424
2023
Q2 		$2.33K Hold
162
– – ﹤0.01% 2451
2023
Q1 		$2.28K Hold
162
– – ﹤0.01% 2419
2022
Q4 		$1.77K Sell
162
-263
-62% -$4.34K ﹤0.01% 2508
2022
Q3 		$9K Buy
425
+42
+11% +$1.14K ﹤0.01% 2202
2022
Q2 		$7K Hold
383
– – ﹤0.01% 2344
2022
Q1 		$11K Buy
383
+233
+155% +$8.51K ﹤0.01% 2348
2021
Q4 		$7K Buy
+150
New +$9.5K ﹤0.01% 2457

Other funds holding HELP

VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
DA
DCF Advisers Greenwich, Connecticut $566M AUM 197.74% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $131M AUM 86.64% 1-Year Est. Return

National Bank of Canada's HELP Position: Q2 2026 in Review

National Bank of Canada increased its Helus Pharma Inc. Common Stock (HELP) stake by 4.4% in Q2 2026, buying an estimated $1.13K and bringing the position to 5,357 shares worth $25.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2189.

National Bank of Canada first reported a position in HELP in Q4 2021 and has held it in 19 quarters since. The position peaked at $32.8K in Q2 2025. 99 funds tracked by Wall St. Rank hold HELP as of Q2 2026.

  • National Bank of Canada held 5,357 shares of Helus Pharma Inc. Common Stock worth $25.1K as of Q2 2026.
  • National Bank of Canada bought 225 Helus Pharma Inc. Common Stock shares in Q2 2026, an estimated $1.13K.
  • Helus Pharma Inc. Common Stock made up ﹤0.01% of National Bank of Canada's portfolio in Q2 2026, its #2189 holding.
  • National Bank of Canada first reported a position in Helus Pharma Inc. Common Stock in Q4 2021 and has held it in 19 quarters since.
  • National Bank of Canada's Helus Pharma Inc. Common Stock position peaked at $32.8K in Q2 2025.
  • 99 funds tracked by Wall St. Rank held Helus Pharma Inc. Common Stock as of Q2 2026.

Based on National Bank of Canada's 13F filing for Q2 2026, filed 10 Aug 2026.